THE Australian Commission on Safety and Quality in Health Care has released new guidance to support health professionals in the day-to-day use of artificial intelligence (AI) tools that are rapidly entering clinical care.

The Commission acknowledges that new AI tools and technologies can bring significant benefits for patient care but can also introduce new risks – especially as evidence of safety and efficacy may lag behind implementation.

To support clinicians to meet their professional responsibilities in using AI tools safely and responsibly, the Commission has developed short and pragmatic guides covering a range of topics.

These include how to check evidence on the efficacy of the AI tool; limitations and risks; transparency and informed consent; implications for patient information; automation bias; and ongoing evaluation and monitoring of AI tools.

Among the supporting documents are an overarching AI clinical use guide, and a safety scenario around the use of AI Scribe tools, which are increasingly used during patient consultations yet have little regulatory oversight.

The guide explains that it is critical to review available information supporting the use of the tool, to discuss its use with the patient and obtain their informed consent, and in particular ensure privacy expectations will be met when it comes to data processing and storage.

Access the guides HERE.

The post Safety and Quality Commission releases AI guidance appeared first on Pharmacy Daily.